Proposed LCD DL40142: MolDX: Biomarker Testing for Risk Stratification in DCIS — Palmetto GBA
Policy LCD-DL40142 · Oncology
New LCD for DCIS testing may impact billing practices.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code D05.10.
Signal breakdown
1 shown · 1 total in platform
Critical
0%
High
100%
Routine
0%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-DL40142 · Oncology
New LCD for DCIS testing may impact billing practices.
Audit documentation
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.